Getting your player ready...
DENVER—Colorado has received $2.6 million as part of a multistate settlement with Eli Lilly & Co. over the way the company marketed the anti-psychotic drug Zyprexa.
Indianapolis-based Lilly agreed in January to a $1.42 billion settlement of criminal and civil cases against it.
Lilly promoted Zyprexa to help dementia patients sleep, but regulators had never approved the drug for dementia.
Colorado Attorney General John Suthers announced the state’s share of the settlement Thursday. He calls it a significant victory against Medicaid fraud.
